UNICREDIT BANK/PUT/ABBVIE/150/0.1/15.01.25 Share Price

Warrant

DE000HC3LGC2

Market Closed - BOERSE MUENCHEN 09:11:01 03/07/2024 pm IST
0.5 EUR +4.17% Intraday chart for UNICREDIT BANK/PUT/ABBVIE/150/0.1/15.01.25
Current month+28.21%
1 month-19.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
03/24/03 0.5 +4.17%
02/24/02 0.48 +26.32%
01/24/01 0.38 -2.56%
28/24/28 0.39 -4.88%
27/24/27 0.41 +13.89%

Real-time BOERSE MUENCHEN

Last update July 03, 2024 at 09:11 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC3LGC
ISINDE000HC3LGC2
Date issued 27/01/2023
Strike 150 $
Maturity 15/01/2025 (196 Days)
Parity 10 : 1
Emission price 2
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.36
Lowest since issue 0.36
Delta-0.27x
Omega 8.198
Premium11.77x
Gearing30.08x
Moneyness 0.9155
Difference Strike -13.84 $
Difference Strike %-9.23%
Spread 0.01
Spread %1.96%
Theoretical value 0.5150
Implied Volatility 24.75 %
Total Loss Probability 65.65 %
Intrinsic value 0.000000
Present value 0.5150
Break even 144.45 €
Theta-0.02x
Vega0.04x
Rho-0.02x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
163.8 USD
Average target price
183.2 USD
Spread / Average Target
+11.84%
Consensus